New Treatment for MMN Patients

Posted on

Baxter International Inc.Baxter International Inc. announces that the U.S. Food and Drug Administration has approved the first immunoglobulin treatment for Multifocal Motor Neuropathy patients in the United States.

Click here to learn more.